ArticleMedicina (Kaunas, Lithuania)2024

Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report.

Charlotte Donzé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.